NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection

被引：6
作者：
Debes, Jose D. [1 ]
Smith, Coleman I. [1 ]
机构：
[1] Univ Minnesota, Plymouth, MN USA
来源：
HEPATOLOGY | 2012年 / 56卷 / 03期
关键词：
GENOTYPE; 1; PROTEIN; REPLICATION; INHIBITOR; BMS-790052;
D O I：
10.1002/hep.25696
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：797 / 799
页数：3
相关论文
共 50 条
[31]   Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the In Vitro Potency of Direct-Acting Antiviral Agents [J].
McPhee, Fiona ;
Ueland, Joseph ;
Vellucci, Vincent ;
Bowden, Scott ;
Sievert, William ;
Zhou, Nannan .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
[32]   Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus [J].
Lee, Wei-Ping ;
Lan, Keng-Li ;
Liao, Shi-Xian ;
Huang, Yi-Hsiang ;
Hou, Ming-Chih ;
Lan, Keng-Hsin .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (05) :368-374
[33]   Fluorescence Resonance Energy Transfer-Based Intracellular Assay for the Conformation of Hepatitis C Virus Drug Target NS5A [J].
Bhattacharya, Dipankar ;
Ansari, Israrul H. ;
Mehle, Andrew ;
Striker, Rob .
JOURNAL OF VIROLOGY, 2012, 86 (15) :8277-8286
[34]   Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection [J].
Spengler, Ulrich .
PHARMACOLOGY & THERAPEUTICS, 2018, 183 :118-126
[35]   Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy [J].
Itakura, Jun ;
Kurosaki, Masayuki ;
Higuchi, Mayu ;
Takada, Hitomi ;
Nakakuki, Natsuko ;
Itakura, Yoshie ;
Tamaki, Nobuharu ;
Yasui, Yutaka ;
Suzuki, Shoko ;
Tsuchiya, Kaoru ;
Nakanishi, Hiroyuki ;
Takahashi, Yuka ;
Maekawa, Shinya ;
Enomoto, Nobuyuki ;
Izumi, Namiki .
PLOS ONE, 2015, 10 (09)
[36]   Subtype-Specific Prevalence of Hepatitis C Virus NS5A Resistance Associated Substitutions in Mainland China [J].
Lu, Jie ;
Feng, Yupeng ;
Chen, Lichang ;
Zeng, Zhengyu ;
Liu, Xianliang ;
Cai, Wei ;
Wang, Hui ;
Guo, Xiaolei ;
Zhou, Huijuan ;
Tao, Wanyin ;
Xie, Qing .
FRONTIERS IN MICROBIOLOGY, 2019, 10
[37]   Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis [J].
de Torres Santos, Ana Paula ;
Martins Silva, Vanessa Cristina ;
Mendes-Correa, Maria Cassia ;
Lemos, Marcilio Figueiredo ;
Malta, Fernanda de Mello ;
Ferraz Santana, Rubia Anita ;
Fernando Dastoli, Gregorio Tadeu ;
Duarte de Castro, Vanessa Fusco ;
Rebello Pinho, Joao Renato ;
Moreira, Regina Celia .
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2022, 64
[38]   Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C [J].
Stirnimann, Guido .
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) :2609-2622
[39]   Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A [J].
Fernandes, Fiona ;
Ansari, Israr-ul H. ;
Striker, Rob .
PLOS ONE, 2010, 5 (03)
[40]   Hepatitis C Virus NS5A Activates Mitophagy Through Cargo Receptor and Phagophore Formation [J].
Hsiao, Yuan-Chao ;
Chang, Chih-Wei ;
Yeh, Chau-Ting ;
Ke, Po-Yuan .
PATHOGENS, 2024, 13 (12)
12345